EE333 Cost-Effectiveness of Once-Weekly Rezafungin for the Treatment of Candidemia and Invasive Candidiasis in the UK

This study assessed the cost-effectiveness of rezafungin versus daily echinocandins for the treatment of C/IC from UK healthcare perspective.

Source: Value in Health - December 1, 2023 Category: International Medicine & Public Health Authors: N. Muszbek, A. Angdembe, C. Garcia-Vidal, I. Bielicka, K. Abrams, K. Tolley, M. Ruhnke, M. Lebmeier, N. Hawkins, N. Manamley, S. Dickerson Source Type: research